-+ 0.00%
-+ 0.00%
-+ 0.00%

Avalon Pharma's Q3 Attributable Net Profit, Revenue Rise

MT Newswires·11/04/2026 00:55:27
Listen to the news
12:55 AM EST, 11/04/2026 (MT Newswires) -- Middle East Pharmaceutical Industries Co. (SASE:4016), d/b/a Avalon Pharma, logged 15.4 million Saudi riyals in net profit attributable to shareholders for the third quarter, compared with 8.3 million riyals a year ago. EPS moved to 0.44 riyal from 0.24 riyal year over year, a Wednesday filing showed. For the three months ended Sept. 30, revenue was 124.4 million riyals versus 108.0 million riyals previously, the Tadawul-listed pharmaceutical company added.